Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
ESGCT 2021
2:44
Challenges with translating gene therapies for neurodevelopmental disorders
Ralf Schmid
• 16 Nov 2021
2:56
Non-viral gene delivery & gene editing: highlights from ESGCT
Ralf Schmid
• 16 Nov 2021
3:06
CAR-Tregs for the treatment of systemic lupus erythematosus
Chiara Bonini
• 22 Nov 2021
3:47
RP-L301 lentiviral gene therapy for PKD
Jose-Luis López-Lorenzo
• 15 Nov 2021
7:24
An update on the Phase I trial evaluating RP-L301 in PKD
Jose-Luis López-Lorenzo
• 15 Nov 2021
3:50
Gene therapy for PKD: addressing the unmet clinical need
Jose-Luis López-Lorenzo
• 15 Nov 2021
3:27
Highlights from ESGCT 2021: gene therapy clinical data, advances in gene editing & AAV toxicity
Paul Wuh-Liang Hwu
• 17 Nov 2021
8:51
Eladocagene exuparvovec: AAV2-mediated gene therapy for AADC deficiency
Paul Wuh-Liang Hwu
• 17 Nov 2021
3:02
Genome editing to address challenges with adoptive T-cell therapy
Chiara Bonini
• 22 Nov 2021
3:04
TCR gene editing in cancer therapy
Chiara Bonini
• 22 Nov 2021
3:13
Developing novel TCR-based T cell products for cancer therapy
Chiara Bonini
• 22 Nov 2021
6:19
LYS-GM101 AAV gene therapy for GM1 gangliosidosis
Michael Hocquemiller
• 15 Nov 2021
3:42
GNT0003: AAV gene therapy for Crigler-Najjar syndrome
Lorenzo D'Antiga
• 18 Nov 2021
3:49
The gene-replacement therapy landscape for CDKL5-deficiency disorder
Ralf Schmid
• 16 Nov 2021
4:31
The safety of AVR-RD-01 gene therapy for Fabry disease
Mark Thomas
• 29 Oct 2021
2:31
The unmet medical need for Crigler-Najjar syndrome
Lorenzo D'Antiga
• 18 Nov 2021
1
2
Next